P

Inventor

CURIEL DAVID T

US37 patents
⚠️ This page may combine multiple inventors who share the name “CURIEL DAVID T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UAB RESEARCH FOUNDATION

27 patents
US5871727AFeb 16, 1999

Targeted adenovirus vectors

UAB RESEARCH FOUNDATION139 citations98
US6955808B2Oct 18, 2005

Capsid-modified recombinant adenovirus and methods of use

UAB RESEARCH FOUNDATION51 citations96
US6716823B1Apr 6, 2004

Noninvasive genetic immunization, expression products therefrom, and uses thereof

UAB RESEARCH FOUNDATION87 citations96
US6348450B1Feb 19, 2002

Noninvasive genetic immunization, expression products therefrom and uses thereof

UAB RESEARCH FOUNDATION159 citations96
US5910486AJun 8, 1999

Methods for modulating protein function in cells using, intracellular antibody homologues

UAB RESEARCH FOUNDATION124 citations96
US6028059AFeb 22, 2000

Methods for modulating protein function in cells using intracellular antibody homologues

UAB RESEARCH FOUNDATION111 citations95
US6699473B2Mar 2, 2004

Human anti-epidermal growth factor receptor single-chain antibodies

UAB RESEARCH FOUNDATION72 citations93
US6333030B1Dec 25, 2001

Chimeric retrovirus/adenovirus system

UAB RESEARCH FOUNDATION24 citations93
US6683170B2Jan 27, 2004

Ligands added to adenovirus fiber

UAB RESEARCH FOUNDATION15 citations90
US6210946B1Apr 3, 2001

Modified adenovirus containing a fiber replacement protein

UAB RESEARCH FOUNDATION20 citations90
US7297542B2Nov 20, 2007

Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob

UAB RESEARCH FOUNDATION18 citations89
US6706693B1Mar 16, 2004

Vaccination by topical application of genetic vectors

UAB RESEARCH FOUNDATION29 citations89
US6284742B1Sep 4, 2001

Immunomodulation by genetic modification of dendritic cells and B cells

UAB RESEARCH FOUNDATION34 citations89
US6824771B1Nov 30, 2004

Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

UAB RESEARCH FOUNDATION34 citations88
US5902583AMay 11, 1999

Genetic induction of receptors for targeted radiotherapy

UAB RESEARCH FOUNDATION40 citations88
US6555368B1Apr 29, 2003

Capsid-modified recombinant adenovirus and methods of use

UAB RESEARCH FOUNDATION16 citations84
US7045127B2May 16, 2006

Human anti-epidermal growth factor receptor single-chain antibodies

UAB RESEARCH FOUNDATION13 citations80
US6841540B1Jan 11, 2005

Immunomodulation by genetic modification of dendritic cells and B cells

UAB RESEARCH FOUNDATION12 citations80
US6689605B1Feb 10, 2004

Controlling immune response to specific antigens

UAB RESEARCH FOUNDATION11 citations72
US6074640AJun 13, 2000

Enhancement of tumor cell radiosensitivity using single chain intracellular antibodies

UAB RESEARCH FOUNDATION12 citations72
US6815200B1Nov 9, 2004

Modified adenovirus containing a fiber replacement protein

UAB RESEARCH FOUNDATION7 citations71
US6312699B1Nov 6, 2001

Ligands added to adenovirus fiber

UAB RESEARCH FOUNDATION6 citations71
US5981504ANov 9, 1999

Genetic induction of receptors for targeted radiotherapy

UAB RESEARCH FOUNDATION11 citations70
US6716622B2Apr 6, 2004

Tissue-specific self-inactivating gene therapy vector

UAB RESEARCH FOUNDATION9 citations66
US6468547B1Oct 22, 2002

Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies

UAB RESEARCH FOUNDATION2 citations61
US6649396B1Nov 18, 2003

Fiber receptor-independent system for the propagation of adenoviral vectors

UAB RESEARCH FOUNDATION6 citations58
US6599909B1Jul 29, 2003

Molecular chemotherapy enhancement of radiotherapy

UAB RESEARCH FOUNDATION6 citations54

BOEHRINGER INGELHEIM INT

6 patents

SELECTIVE GENTICS INC

1 patent

UNIV WASHINGTON

1 patent

(unassigned)

1 patent

UNLEASH IMMUNO ONCOLYTICS INC

1 patent